Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Gains (Losses) on Sale of Assets & Investments (2021 - 2025)

Updated

Analysis

Artelo Biosciences (ARTL) Gains (Losses) on Sale of Assets & Investments (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 22,000.00
Dec 31, 2024 -248,000.00
Sep 30, 2024 63,000.00
Jun 30, 2024 79,000.00
Mar 31, 2024 106,000.00
Dec 31, 2023 167,000.00
Sep 30, 2023 165,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 124,000.00
Dec 31, 2022 137,000.00
Sep 30, 2022 69,000.00
Jun 30, 2022 21,000.00
Mar 31, 2022 -22,000.00
Nov 30, 2021 3,000.00
May 31, 2021 984.00
Feb 28, 2021 1,335.00
API Access

Artelo Biosciences Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ARTL&period=max&api_key=YOUR_API_KEY